The AusHealth Oral 7® is used for qualitative detection of seven (7) commonly abused drugs and drug metabolites including amphetamine, opiates, cocaine, methamphetamine / MDMA, benzodiazepines and Δ9-tetrahydrocannabinol (THC) in human oral fluid.
Oral fluid drug testing is now a viable alternative to the widely used urine drug testing procedure. Oral fluid collection can be conveniently and repeatedly performed under a variety of circumstances.
HOW Oral 7® WORKS
Oral 7® testing is based on a competitive lateral flow immunoassay to qualitatively detect illicit drugs and their metabolites in human oral fluid. Drug antibodies are conjugated to colloidal gold nanoparticles.
After oral fluid is applied to the test device, the nanoparticle-antibody conjugate will flow and bind to the drug conjugate line located on the nitrocellulose membrane of the test strip forming a red color line for each drug target. If the oral fluid sample contains drug, the drug molecule will competitively bind to the antibody on the gold nanoparticles.
The antibody-gold conjugate nanoparticles will not bind the drug conjugate on the membrane and therefore no colored line will be formed (a non-negative result).
Oral 7® is uniquely designed for user-friendly on-site rapid drug testing using an oral fluid specimen (5-10 minutes).
The Oral7® detects the following drugs in oral fluid, to the relevant target concentrations:
Target Concentrations (ng/mL)
|Cocaine and metabolites||50|
NOTE: The cut-offs apply to the concentration in the neat oral fluid specimen (obtained from the donor).